Neeraj Agarwal

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Urology, Oncology, Docetaxel Chemotherapy +9

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · The Lancet Oncology · 2013 · 1K citations · Full text

External Validation, Urology, Population-based Study +9

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · The Lancet Oncology · 2016 · 927 citations · Full text

Urology, Genitourinary Cancer, Kidney Research +8

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 619 citations · Full text

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2017 · 573 citations · Full text